Notably, IL-13 levels have been clinically correlated with erythrocyte sedimentation rates, C-reactive protein levels, and the number of nailfold capillaroscopy abnormalities, which are predictors of mortality in patients with SSc [24, 25]. Here, IL13 is linked to systemic sclerosis.